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ABSTRACT
RNA interference (RNAi) is a valuable technique to
determine gene function. In Caenorhabditis elegans,
RNAi can be achieved by feeding worms bacteria
carrying a plasmid expressing double-stranded RNA
(dsRNA) targeting a gene of interest. The most com-
monly used plasmid vector for this purpose is L4440.
However, it has been noticed that sequences within
L4440 may elicit unspecific effects. Here, we pro-
vide a comprehensive characterization of these ef-
fects and their mechanisms and describe new un-
expected phenotypes uncovered by the administra-
tion of unspecific exogenous dsRNA. An example in-
volves dsRNA produced by the multiple cloning site
(MCS) of L4440, which shares complementary se-
quences with some widely used reporter vectors and
induces partial transgene silencing via the canoni-
cal and antiviral RNAi pathway. Going beyond trans-
gene silencing, we found that the reduced embry-
onic viability of mir-35-41(gk262) mutants is par-
tially reversed by exogenous dsRNA via a mecha-
nism that involves canonical RNAi. These results in-
dicate cross-regulation between different small RNA
pathways in C. elegans to regulate embryonic via-
bility. Recognition of the possible unspecific effects
elicited by RNAi vectors is important for rigorous in-
terpretation of results from RNAi-based experiments.
INTRODUCTION
RNA interference (RNAi) is an evolutionarily conserved
pathway used by multiple species as a mechanism of genome
surveillance, antiviral defense and/or gene silencing (1).
Given its widespread application, RNAi has been used as
a powerful discovery tool, as well as a biotechnological
and pharmaceutical asset (2). The identification that exoge-
nous double-stranded RNA (dsRNA) can target and silence
RNAs in animals was first made in Caenorhabditis elegans,
when it was shown that injection of dsRNA molecules into
worms results in silencing of genes that express similar se-
quences (3). In C. elegans, long dsRNA is recognized by
the dsRNA-binding protein RDE-4 and then cleaved by the
type III ribonuclease DCR-1 to generate shorter dsRNA
fragments of ∼22 base pairs (i.e. siRNA) (4–6). Short single-
stranded RNA fragments are afterward loaded onto the
Argonaute RDE-1 to promote gene silencing (7). Upon
matched complementarity, the target RNA is degraded (8).
The first RNAi experiments used microinjection to de-
liver dsRNA to C. elegans, but later it was shown that RNAi
can also be induced by feeding worms with bacteria harbor-
ing a plasmid in which the target gene sequence is partially
cloned into a multiple cloning site (MCS) flanked by two an-
tiparallel T7 promoters (9). The antiparallel T7 promoters
produce dsRNA in the bacteria, which in turn targets the
gene of interest in the worm when ingested (9). Using this
strategy, RNAi feeding libraries were generated by two dif-
ferent groups using the L4440 plasmid (a modified version
of the pBlueScript plasmid) (10,11) and the Escherichia coli
strain HT115 (DE3)––a strain carrying a defective RNase
*To whom correspondence should be addressed. Marcelo A. Mori. Tel: +55 19 3521 6232; Email: morima@unicamp.br
C© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work







niversidade Estadual de C
am
pinas user on 28 M
ay 2020
3958 Nucleic Acids Research, 2019, Vol. 47, No. 8
III and an isopropylthiogalactoside (IPTG)-inducible T7
polymerase gene (12). Given their whole genome coverage
and easy access, these libraries are frequently used as the de-
livery method of choice for RNAi-mediated gene silencing
in C. elegans.
Another commonly used technique in C. elegans is the
generation of transgenic lines expressing tagged fluorescent
proteins (13). These transgenes are often used as readouts
for protein subcellular localization and gene expression, but
in some genetic backgrounds, such as in lin-35 mutants, they
can be silenced in somatic cells simply by the activation of
the RNAi pathway (14). Curiously, microRNAs as the mir-
35-41 cluster regulate RNAi responsiveness through lin-35
(15), and differently from most of the microRNAs in C. el-
egans, loss of mir-35-41 leads to severe phenotypes, such as
a temperature-sensitive reduction in progeny viability and
fecundity (16,17). These results suggest a possible physi-
ological crosstalk between the RNAi pathway, transgene
silencing, microRNA expression, embryonic development
and germline function.
Years of experiments using RNAi in C. elegans have re-
vealed unexpected results in our hands and in the hands
of others. It has been previously observed that the back-
bone of the L4440 vector silences transcription of somatic,
LacZ-containing transgenes in a mechanism named RNAi-
induced Transcriptional Gene Silencing (RNAi-TGS) (18).
This mechanism involves chromatin modifier proteins (e.g.
HPL-2) and the canonical RNAi machinery (18). Non-
specific dsRNA targeting the bacterial tetA gene was also
found to promote GFP silencing in transgenic worms (19).
In this study, we provide a comprehensive analysis of con-
ditions where worms have their phenotypes modified when
grown in the presence of exogenous dsRNA, in particular
the type produced by the L4440 vector. We describe new
mechanisms of multicopy transgene silencing by the L4440
vector and observe that exogenous dsRNA interferes with
embryonic development of a mir-35-41 mutant strain. We
therefore conclude that unspecific effects can be much more
common than previously anticipated when using standard
RNAi techniques. We describe these effects and their mech-
anisms as a cautionary note for the unrestrictive use of the
RNAi technology and introduce new variables for consid-
eration in RNAi studies in C. elegans and potentially other
species.
MATERIALS AND METHODS
Strains and maintenance of C. elegans
Nematodes were maintained under standard conditions as
previously described (20,21). In short, they were kept at
20◦C in streptomycin (100 g/ml) supplemented Nema-
tode Growth Medium (NGM) with a lawn of OP50-1 E.
coli as the food source, unless stated otherwise. Strains with
glp-1(e2141) background were maintained at 15◦C to pre-
vent infertility and were grown at 25◦C during experiments.
Strains used in this study, including transgenes and co-
injection markers are described in Supplementary Table S1.
Some strains were provided by the Caenorhabditis Genetics
Center (Minneapolis, MN).
RNAi by feeding
RNAi plates were supplemented with 1 mM of Iso-
propyl -D-1-thiogalactopyranoside (IPTG), tetracycline
(12.5 g/ml) and ampicillin (100 g/ml), unless stated oth-
erwise. HT115(DE3) E. coli bacteria transformed with the
L4440 vector (empty vector or carrying specific fragments
of cDNA) were inoculated in LB medium overnight. When
HT115(DE3) was used without a vector, only tetracycline
and IPTG were added to NGM. RNAi clones were available
from the Ahringer’s RNAi library. Double RNAi assays
were performed as previously described (22–24). Briefly,
worms were fed a 1:1 mixture of two sorts of RNAi bac-
teria grown overnight (OD = 1.5) and concentrated (10×).
The RNAi clone targeting luciferase was generated pre-
viously (25). For mir-35-41(gk262) mutant experiments,
RNAi plates were prepared using 6 mM of IPTG.
Cloning
For MCS removal [L4440 (-MCS)], we digested the L4440
vector with BglII and KpnI, blunted the ends using T4
DNA polymerase and religated the plasmid using the Quick
Ligation kit (New England Biolabs). For T7 promoter re-
moval [L4440 (-T7)], we PCR amplified the L4440 vec-
tor backbone sequence upstream of the T7 promoters. The
PCR fragment was ligated into the L4440 MCS. This specif-
ically removed the T7 promoters maintaining the remain-
ing of the L4440 plasmid including the MCS. Additional
digestions were performed with KpnI and XmaI to remove
part of the MCS. All these plasmids were confirmed by se-
quencing (data not shown). L4440 (GFP) was a gift from
the Ruvkun lab. Plasmids were transformed into TOP10 E.
coli (One Shot® iTOP10 Chemically Competent E. coli),
clones were selected and DNA was extracted using QIA-
GEN Plasmid Mini Kit followed by enzyme digestions or
sequencing confirmation. Plasmids were then used to trans-
form HT115(DE3) E. coli, which was used to feed worms.
mir-35-41(gk262) viability
Worm viability was assayed as previously described (15).
Briefly, mir-35(gk262) worms were kept at 20◦C, synchro-
nized by standard bleaching procedure and the yielding eggs
were left to hatch in M9 buffer at 20◦C. After hatching,
∼100 animals were pipetted onto plates containing RNAi
bacteria and transferred to 25◦C. Forty-eight hours later,
three adult/late L4 worms were transferred to new plates of
the same RNAi and were allowed to lay eggs at 25◦C for
24 h. After 24 h, parents were removed from each plate and
the number of fertilized eggs laid and hatched larvae were
counted. Forty hours later, viable progeny (L3 or older)
was scored and the percentage of progeny viability was cal-
culated as the ratio of viable progeny/laid eggs. Unfertil-
ized oocytes were not included in the counting. For ex-
periments done in Figure 5A, a single mir-35-41(gk262)
hermaphrodite grown for 50 h at 25◦C in HT115(DE3) was
crossed with mir-35(gk262) II, wwIs8 [mir-35-41p::GFP +
unc-119(+)]) male worms grown for 60 h at permissive tem-
perature (15◦C). The worms were kept crossing for 24 h at
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counted. After 48 h, GFP positive L3 worms were counted
and progeny viability was calculated.
RNA extraction and RT-qPCR
Worms were harvested in TRIzol (Life Technologies). To-
tal RNA was extracted as previously described (26). For
GFP and pre-GFP mRNA quantification, worms were
kept at 35◦C for 1 h before RNA extraction to induce
daf-16 expression in the N2 background. cDNA was pro-
duced using High-Capacity cDNA Reverse Transcription
kit (Life Technologies). Quantitative reverse-transcriptase
PCR (RT-qPCR) was performed using Maxima SYBR-
Green Master Mix (Fermentas) in an ABI 7000 detection
system (Applied Biosystems), and his-10 was used as en-
dogenous control. Primer sequences used in this work can
be found in Supplementary Table S2.
dsRNA synthesis and microinjection
cDNA corresponding to gfp was PCR amplified using the
L4440-GFP plasmid as a template and a pair of primers
containing T7 and SP6 promoter sequences. The PCR prod-
uct was gel purified using Qiagen gel purification kit and
eluted in DEPC-treated water. For ssRNA synthesis, two
separate in vitro transcription reactions were done using 200
ng of the purified PCR and the RNA polymerases T7 and
SP6 (Epicentre), followed by DNAse I treatment. Each re-
action was phenol:chloroform purified and 5 g/l of each
strand were mixed in injection buffer (33 mM Na2HPO4,
16 mM KH2PO4, 6 mM NaCl, 14 mM NH4Cl) and an-
nealed at 68◦C for 10 min and 37◦C for 40 min. For dsRNA
injection, mir-35-41(gk262) worms were first crossed into
the PD4251 strain containing an integrated array made by
three plasmids: pSAK2 (myo-3 promoter driving nuclear-
targeted GFP-LacZ fusion); pSAK4 (myo-3 promoter driv-
ing mitochondrial-targeted GFP) and dpy-20 as a selectable
marker. The PD4251 strain produces GFP in the nucleus
and mitochondria of all body muscle cells, so we could mon-
itor whether injection with gfp RNAi worked by observing
worm’s fluorescence under the microscope. Microinjections
were done in both gonad arms of L4 mir-35-41(gk262);
PD4251 worms grown at 25◦C from starved L1s (hatched
on at 20◦C). After a 2-h recovery period, the injected worms
were singled on NGM plates and allowed to lay embryos
for 24 h. The injected parents were picked off the plates and
their progeny was counted. Two days later, we scored the
non-green progeny that reached the L3 stage. Those worms
were phenotypically viable and rescued by the gfp RNAi. As
a control we injected mir-35-41(gk262); PD4251 with injec-
tion buffer.
dsRNA synthesis and soaking
PCR fragments flanked by the T7 promoters of L4440,
L4440 (gfp) or L4440 (rde-1) plasmids were amplified
and used as templates for dsRNA synthesis using the
MEGAscript T7 Transcription Kit (ThermoFisher). We
followed the manufacturer’s protocol and synthesized
dsRNA for 16 h at 37◦C. The product was treated with
TURBO DNase (Invitrogen) and purified using TRIzol
(ThermoFisher). Soaking was done by adding 1 l of
ddH2O containing ∼100 synchronized L1 worms to 10 l
soaking buffer (5.5 mM KH2PO4; 10.5 mM Na2HPO4; 17.2
mM NaCl; 0.05% gelatin; 3 mM spermidine) containing 8
g dsRNA. Worms were maintained at 20◦C for 48 h and
then transferred to 60-mm plates until day 0 of adulthood,
when phenotypes were assessed.
Identification of L4440-produced dsRNA
RNAi plates were prepared with the addition or not of
IPTG. Plates were seeded with bacteria harboring L4440
or gfp RNAi and incubated overnight at room temperature
for T7 polymerase induction by IPTG and production of
dsRNA. On the next day, plates were washed with LB and
centrifuged at 4◦C, 8000 × g for 4 min. Total RNA was ex-
tracted by addition of 1 ml TRIzol to bacterial pellet. Sam-
ples were homogenized by quick vortex, incubated at 68◦C
for 5 min and RNA was extracted according to manufac-
turer’s protocol. A 10 l reaction mix containing 5 g of
total bacterial RNA, 0.32 M NaCl and 0.1 ng/l RNase A
was incubated for 5 min at 37◦C. Samples were purified by
phenol:chloroform:isoamyl acid (29:28:1) extraction, resus-
pended in 15 l DEPC-treated water and 10 l were loaded
onto a 1% agarose gel.
For RT-qPCR, L4440 vector plus or minus MCS was
grown overnight on LB media. Bacteria were 10× concen-
trated and split into two vials. One vial was incubated at
20◦C overnight with 1 mM IPTG and the other with vehi-
cle. In the following day, cultures were centrifuged at 4◦C,
8000 × g for 4 min. The supernatant was discarded, 500 l
of TRIzol was added to bacterial pellet, and total RNA was
extracted and subjected to DNAse treatment. cDNA RT-
qPCR was performed as described before, and E. coli gyrA
was used as endogenous control.
Microscopy and quantification of GFP
For DCR-1::GFP quantification, synchronized worms on
day 0 of adulthood were anesthetized using 0.1% sodium
azide and scanned using InCell Analyzer 2200 (GE Health-
care). GFP fluorescence was quantified in the posterior in-
testine region located right after the spermatheca, where the
DCR-1::GFP is specific (27). For the nuclear localization
assays of DAF-16::GFP or GFP::DAF-16, animals were
anesthetized using 0.1% sodium azide on day 0 adult stage,
and the number of worms with nuclear GFP in intestinal
cells was quantified (InCell Analyzer 2200, Cytation 5, or
Zeiss Axio Imager Z1 microscopes). We scored a worm as
having nuclear DAF-16 localization if at least 20% of its
intestinal cells had noticeable GFP signal in the nucleus.
For some experiments, in order to facilitate visualization
of DAF-16::GFP, worms were exposed to heat shock treat-
ment at 34◦C for 1 h. Representative images were shown in
some pictures. All images were processed using ImageJ soft-
ware (http://rsbweb.nih.gov/ij/).
Statistical analysis
Results are presented as mean ± S.E.M. Statistical tests
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Figure 1. Transgenes are silenced upon the exposure of worms with HT115 bacteria harboring the L4440 vector. Worms were grown on plates seeded with
different bacterial strains. OP50-1 is the standard E. coli feeding bacteria. HT115 is the RNAi feeding E. coli strain, and it may carry the L4440 plasmid
for the production of dsRNA (L4440). L4440 targeting gfp was used as a positive control (L4440-gfp). All experiments were performed three times with
at least six worms per group each time. Representative images using a 4× objective microscope of worms on day 0 of adulthood. (A) MAM13/ mamIs1
[dcr-1p::DCR-1::GFP + pUN24 (Y66H1B.3p::Y66H1B.3::GFP) + pJK590 (lag-2p::GFP)] strain was grown at 20◦C, photographed and fluorescence
was quantified. Arrows indicate the area used for fluorescence quantification (posterior intestine region) (B). CF1935/ daf-16(mu86) I; glp-1(e2141)
III; muIs109 (daf-16p::GFP::DAF-16 cDNA + odr-1p::RFP) worms were grown at 25◦C to suppress the germline, and DAF-16 nuclear localization was
observed in intestinal cells on day 0 of adulthood. (C) MS438/ irIs25 [elt-2::NLS::GFP::lacZ + rol-6(su1006)] strain was grown at 20◦C. Dashed lines
represent worm area. ***P < 0.001; compared to OP50-1, using one-way ANOVA and Dunnett’s multiple comparison post-hoc test.
using one-way ANOVA (more than two groups), two-
tailed student’s t-test (two groups, equal variance) and non-
parametric test (two groups, unequal variance).
RESULTS
RNAi vectors silence different transgenes in C. elegans
In a standard RNAi protocol for C. elegans, worms
are fed with dsRNA-expressing HT115(DE3) bacteria
(henceforth called HT115 for simplicity) transformed with
the L4440 plasmid (9). Our experience using this pro-
tocol led us to intriguing observations that we consid-
ered important to report here. We observed that inges-
tion of HT115 bacteria carrying the RNAi empty vector
L4440 resulted in diminished fluorescence in three inde-
pendent transgenic strains expressing multicopy GFP re-
porters: MAM13/ mamIs1 [dcr-1p::DCR-1::GFP + pUN24
(Y66H1B.3p::Y66H1B.3::GFP) + pJK590 (lag-2p::GFP)]
(Figure 1A), CF1935/ daf-16(mu86) I; glp-1(e2141) III;
muIs109 [daf-16p::GFP::DAF-16 cDNA + odr-1p::RFP]
(Figure 1B) and MS438/ irIs25 [elt-2::NLS::GFP::lacZ +
rol-6(su1006)] (Figure 1C). The dcr-1p::DCR-1::GFP con-
struct is based on the pPD95.75 vector backbone and was
successfully used to rescue the dcr-1(ok247) null allele
(27). The daf-16p::GFP::DAF-16 cDNA construct in the
muIs109 transgene uses part of the L2911/pPD103.87 vec-
tor backbone and is widely applied in the aging field to res-
cue daf-16 mutations and to report DAF-16 expression and
sub-cellular localization (28–33). elt-2::NLS::GFP::lacZ is
an elt-2 reporter construct based on the pPD96.04 vector
that was found before to be silenced by L4440 (18). In all
cases, more than 90% of the worms had at least 50% of
transgene fluorescence silenced upon L4440 exposure.
LacZ-containing transgenes like the irIs25 were shown
to be silenced by complementary RNA expressed by
the backbone of L4440 (18) (for L4440 map and se-
quence, see Supplementary Figure S1 and Information).
Hence, the majority of the clones obtained from L4440-
based RNAi libraries are expected to inhibit irIs25 [elt-
2::NLS::GFP::lacZ + rol-6(su1006)] expression and po-
tentially other LacZ-harboring transgenes. Likewise, all
L4440-based RNAi clones that we tested silenced mamIs1
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Figure 2. L4440 silences different transgenes using distinct pathways.
(A) Representative experiment showing quantification of mamIs1 [dcr-
1p::DCR-1::GFP + pUN24 (Y66H1B.3p::Y66H1B.3::GFP) + pJK590
(lag-2p::GFP)] fluorescence in at least 10 worms grown on plates
seeded with HT115 bacteria without the RNAi cloning vector or car-
rying different RNAi clones. OP50-1 was used as a reference. Experi-
ment was repeated three times. (B) Percentage of worms with at least
20% of intestinal cells with nuclear GFP localization. The CF1935/ daf-
16(mu86) I; glp-1(e2141) III; muIs109 [daf-16p::GFP::DAF-16 cDNA +
odr-1p::RFP] strain was used. Mean of at least three biological replicates
with at least 10 worms per group. *** P < 0.001; compared to L4440, using
one-way ANOVA and Tukey’s multiple comparison post-hoc test. **P <
0.01 and *** P < 0.001
(Y66H1B.3p::Y66H1B.3::GFP) + pJK590 (lag-2p::GFP)]
transgenes, independently of whether these transgenes were
integrated into the genome or were extrachromosomal ar-
rays (Supplementary Figure S2 and data not shown). Inter-
estingly, these transgenes do not contain LacZ sequences,
but their shuttle vector (i.e. pPD95.75) exhibited significant
overlap with the L4440 vector at their backbones (align-
ments displayed at the Supplementary Material).
Interestingly, muIs109 [daf-16p::GFP::DAF-16 cDNA +
odr-1p::RFP] also does not contain LacZ sequences, but in
contrast to the dcr-1-expressing transgenes, it was silenced
by some, but not all tested L4440-based RNAi clones, argu-
ing that the backbone of the L4440 plasmid alone cannot
explain this phenotype (Figure 2B). Moreover, we observed
marginally significant, 5- to 10-fold decreases in daf-16 (P
value = 0.381) or DAF-16 target sod-3 (P value = 0.0476)
mRNA expression, respectively, when CF1935 worms were
fed L4440-harboring bacteria (Supplementary Figure S3A
and B). Despite the variation in the control group, L4440
exposure resulted in a robust 74% reduction in gfp mRNA
expression, while there were no significant changes at the
pre-mRNA level, suggesting that cytoplasmic silencing is
the main responsible for the L4440 effect (Supplementary
Figure S3C). To exclude the possibility that L4440 was tar-
geting the daf-16 pathway itself, we measured dauer entry (a
daf-16-dependent phenotype) in daf-2(e1370) mutants and
found that the vector did not interfere with the penetrance
of the phenotype (Supplemental Figure S4A). Additionally,
we did not observe L4440-induced transgene silencing us-
ing an alternative DAF-16 reporter construct where GFP
was fused to the C-terminus of DAF-16 [i.e. zIs356 (daf-
16p::DAF-16a/b::GFP; rol-6)] (Supplementary Figure S4B
and C). Together, these data demonstrate that the L4440
vector targets specific transgenes and silences them through
distinct mechanisms.
dsRNA expressed by the L4440 vector acts through the RNAi
pathway to silence the muIs109 transgene
Importantly, we observed that L4440 produces a non-
specific dsRNA from its MCS (Supplementary Figure S5A–
D), which does not match any genomic or transcriptomic
sequence in C. elegans (Supplemental Figure S5E), or the
irIs25 and zIs356 transgenes (data not shown), but does
target two complementary sequences in the muIs109 trans-
gene, which were carried with the gfp sequence from the
L2911/pPD103.87 vector and fused with the daf-16 gene
(34) (Supplemental Figure S6A) (sequences for transgenes
and L4440 can be accessed in Supplementary Material).
The two matching sequences had a 47-bp long size with
identity of 94% and E value of 3 × 10−15 and a 38-bp long
size with identity of 100% and E value of 9 × 10−16, respec-
tively. We hypothesized that these matches determine how
the L4440 vector silences the muIs109 transgene.
Indeed, we removed the MCS region or the T7 promoters
of the L4440 plasmid [L4440 (-MCS) and L4440 (-T7), re-
spectively] and found that the vector could no longer silence
the muIs109 transgene (Figure 3A). In contrast, the irIs25
transgene was silenced by the L4440 (-MCS) vector but not
by the L4440 (-T7) construct (Figure 3B), in agreement with
a role of the backbone in this particular modality of trans-
gene silencing. Furthermore, when we used an RNAi con-
struct in which the MCS of L4440 was totally replaced by
the luciferase gene or when we removed part of the L4440
MCS region that is complementary to the muIs109 trans-
gene, we blunted L4440-mediated silencing (Supplementary
Figure S6B). To further support our hypothesis, when we
tested other GFP-expressing transgenes constructed using
GFP derived from vectors similar to the one used to con-
struct muIs109 (i.e. pBluescript-based vectors), we found
that they were also silenced by L4440 (Table 1) (27,28,35–
40). Importantly, all of these vectors had sequences that sig-
nificantly overlapped with L4440, while the muIs109 and
ccIs4810 transgenes specifically overlapped with the MCS
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Figure 3. L4440 inhibits muIs109 expression in an RNAi machinery-dependent manner. (A) Quantification of worms exhibiting GFP::DAF-16 nuclear
localization in the CF1935/ daf-16(mu86) I; glp-1(e2141) III; muIs109 [daf-16p::GFP::DAF-16 cDNA + odr-1p::RFP] strain grown on HT115 harboring
L4440 with or without MCS (-MCS) or T7 (-T7) promoter elements. ***P < 0.001 compared to L4440, using one-way ANOVA and Tukey’s multiple
comparison post-hoc test. (B) MS438/ irIs25 [elt-2::NLS::GFP::lacZ + rol-6(su1006)] worms grown on HT115 harboring L4440 with or without MCS or
T7 promoters. Representative images using an 10× objective microscope (GFP, lower panels and phase contrast, upper panels). (C) CF1935/ daf-16(mu86)
I; glp-1(e2141) III; muIs109 [daf-16p::GFP::DAF-16 cDNA + odr-1p::RFP] worms were grown on OP50-1 or HT115 bacteria harboring L4440 or in a
double RNAi 1:1 mix of HT115 (L4440) and HT115 (L4440 + dcr-1 RNAi) or HT115 (L4440 + pos-1 RNAi). Single RNAi against dcr-1 or pos-1 did
not compromise muIs109 (daf-16p::GFP::DAF-16 cDNA + odr-1p::RFP) nuclear localization (data not shown and Figure 2B). MAM56/rde-1(ne219);
daf-16(mu86) I; glp-1(e2141) III; muIs109 (daf-16p::GFP::DAF-16 cDNA + odr-1p::RFP) worms were grown on OP50-1, HT115 harboring L4440 or
daf-16 RNAi. + or - represents when worms exhibited GFP expression comparable to control or when GFP expression was silenced, respectively. Silencing
was defined when more than half of a group of worms had <20% of intestinal cells with GFP localization. All experiments were performed three times
with at least eight worms per group each.
Table 1. List of transgenes silenced or not by L4440
Transgene Platform Silenced by L4440 Strain name
muIs109 Bluescript II KS+ L2911 Yes CF1935
mamIs1 Bluescript-like L2463 Yes MAM13
ccIs4810 Bluescript II KS+ L2822 Yes YG1021
juIs176 pUC19-derived L3471 No CZ3464
mnIs35 pUC19-derived L3827 No SP2533
qcEx24 pUC19-derived L3828 No CS119
oxSi259 Generated by MosSCI No EG6173
bq12 Generated by CRISPR No BN580
Worms were grown on plates with HT115 harboring or not L4440 in the presence or not of IPTG for dsRNA induction. Worms were observed at day 0 of
adulthood to check if GFP fluorescence was inhibited by the presence of L4440 + IPTG. The experiment was repeated twice and 10 images with at least
20 worms total were analyzed and total fluorescence was quantified using ImageJ (data not shown). The strains tested were previously described: CF1935
(28), MAM13 (27), YG1021 (35), CZ3464 (36), SP2533 (37), CS119 (38), EG6173 (39), BN580 (40). Shaded rows represent transgenes silenced by L4440
as scored by a blind observer based on the respective controls. CF1935 and YG1021 were not silenced by L4440(-MCS) (Figure 2 and data now shown).
was not the case for transgenes where GFP was derived
from pUC19 plasmids or inserted in the genome by pre-
cise techniques such as MosSCI or CRISPR (Table 1 and
Supplementary Material). These results demonstrate that
the L4440 MCS targets specific complementary sequences
in some transgenes, in particular the ones where sequences
of pBluescript-based plasmids remained in the construct.
Consistent with a role of dsRNA produced by the
MCS, L4440-mediated muIs109 transgene silencing was de-
pendent on components of the RNAi pathway such as
RDE-1 and DCR-1 (Figure 3C and Supplemental Figure
S7). These results provide evidence that the pathways for
transgene suppression by the L4440 vector involve RNA-
mediated silencing but differ in their mechanism depend-
ing on the RNA produced and the target (i.e. muIs109 ver-
sus irIs25 transgene). To directly test the role of L4440-
produced dsRNA to silence the muIs109 transgene, we
delivered by soaking the dsRNA synthesized in vitro us-
ing the MCS region of the L4440 plasmid as a template.
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Figure 4. MCS dsRNA from L4440 silences muIs109 expression. Quan-
tification of fluorescence of (A) MAM13/ mamIs1 [dcr-1p::DCR-1::GFP
+ pUN24 (Y66H1B.3p::Y66H1B.3::GFP) + pJK590 (lag-2p::GFP)], (B)
MAM71/ N2; muIs109 [daf-16p::GFP::DAF-16 cDNA + odr-1p::RFP]
and (C) MS438/ irIs25 [elt-2::NLS::GFP::lacZ + rol-6(su1006)] treated
with soaking buffer (buffer), MCS dsRNA of L4440 (dsMCS), GFP
dsRNA (dsGFP) or rde-1 dsRNA (dsRDE-1) at day 0 of adulthood for
48 h before analysis. All experiments were performed three times with at
least 10 worms per group each time. *P < 0.05, ***P < 0.001 compared to
‘buffer’ using one-way ANOVA and Tukey’s multiple comparison post-hoc
test.
expressing worms, but not in mamIs1 or with a lesser mag-
nitude in irIs25 transgenic (Figure 4), reinforcing the neces-
sity and the specificity of L4440-produced dsRNA to silence
the transgenes.
Furthermore, to better comprehend the mechanism un-
derlying the L4440 effect over the muIs109 transgene, we
performed a double RNAi screen directed against genes in-
volved in small RNA pathways. As expected, we confirmed
that components of the canonical RNAi pathway (i.e. dcr-
1, rde-1, rde-4, and mut-16) were necessary for muIs109
silencing (Table 2). We also identified drh-1 and rsd-6 as
genes required for L4440-mediated silencing (Table 2). drh-
1 and rsd-6 are both involved in the antiviral RNAi path-
way (41,42). Interestingly, we observed that RNAi target-
ing these genes did not block the silencing effect medi-
ated by daf-16 RNAi (data not shown), hinting that L4440
acts through a non-canonical RNAi pathway that involves
drh-1 and rsd-6. However, L4440 (or daf-16 RNAi) could
still silence the muIs109 transgene in drh-1(ok3495) or rsd-
6(pk2011) mutants (Supplementary Figure S8A and B).
Given that in the mutant strains drh-1 or rsd-6 are lost dur-
ing the worm’s entire life cycle and in the double RNAi ex-
periments genes are silenced concomitantly starting at L1,
we hypothesized that differences when these genes are lost
could explain such discrepancies. Consistent with this no-
tion, when we started applying rsd-6 RNAi in utero, L4440
was able to silence the muIs109 transgene (Supplementary
Figure S8C).
Exogenous dsRNA increases progeny viability of a miRNA
mutant strain
mir-35-41 mutants exhibit reduced progeny viability when
grown at restrictive temperature (25◦C), and this has been
linked to embryonic and larval lethality (15,16,43,44). We
found that reduced progeny viability of mir-35-41(gk262)
hermaphrodites grown at the restrictive temperature (25◦C)
was paternally rescued when these worms were crossed
with mir-35-41(gk262) males grown at permissive tem-
perature (15◦C) (Figure 5A). Remarkably, we also found
that the mir-35-41(gk262) mutant had its progeny viabil-
ity of 5% increased to over 30% when worms were fed
with HT115 carrying L4440 (Figure 5B). L4440 also pro-
moted fecundity of mir-35-41(gk262) mutants at 25◦C, as
evidenced by increased brood size (Supplementary Figure
S9A). The partial rescue of progeny viability by L4440 was
only observed when worms were grown on plates contain-
ing IPTG (inducer of T7 RNA polymerase). These find-
ings led to the important and novel conclusion that the ef-
fects of L4440 go beyond transgene silencing. However, in
this case, a L4440-based gfp RNAi clone also suppressed
the decrease of progeny viability in the mir-35-41(gk262)
mutant (Figure 5B). Since the mir-35-41(gk262) mutant
does not carry transgenes that could be affected by com-
plementarity with the L4440 backbone and we could not
find significant overlap between the L4440 backbone and
the genome of C. elegans, we hypothesized that dsRNA gen-
erated by L4440 could result in general activation of the
RNAi pathway and consequently rescue progeny viability.
To test whether the phenotype was caused by the L4440
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injected gfp-targeting dsRNA into L3 worms and it recov-
ered the progeny viability of mir-35-41(gk262) mutants to
30% (Figure 5C). This confirms that the mir-35-41(gk262)
phenotype suppression occurs independently of the L4440
plasmid and is associated with the presence of exogenous
dsRNA.
To better understand the mechanisms, we performed
double RNAi screen targeting components of small RNA
pathways (the same genes are listed in Table 2) and asked
whether any of the clones interfered with the L4440 effect
(Table 3). We observed that the majority of the RNAi clones
partially recovered progeny viability in mir-35-41(gk262)
mutants, once again confirming that dsRNA production is
sufficient to attenuate the phenotype. Consistent with this
observation, the effect of exogenous dsRNA on mir-35-
41(gk262) progeny viability depended on canonical com-
ponents of the RNAi machinery (i.e. rde-4, rde-1, dcr-1
and mut-7) (45) (Table 3). Importantly, we confirmed these
findings by crossing mir-35-41(gk262) mutants with rde-
4(ne301) mutants, where loss of an important gene involved
in dsRNA processing blocked the effects of L4440 (Fig-
ure 5D). This was not due to a potential outcross of mir-
35-41(gk262) mutants since the effect of L4440 was pre-
served even when these worms were outcrossed to a wild-
type background for one further generation (Supplemen-
tary Figure S9B). We also found that knockdown of genes
involved in miRNA biogenesis (i.e. dcr-1 and pash-1) coun-
teracted the effects of L4440 on mir-35-41(gk262) mutants
(Table 3), although silencing of dcr-1 and pash-1 also re-
duced progeny viability in wild-type worms (Supplementary
Figure S9C).
Finally, by timing RNAi exposure in mir-35-41(gk262)
mutants, we found that the decrease in progeny viability
could only be reversed if a source of dsRNA was given to
parents starting at the L1 stage and remained during in utero
development of the progeny (Supplementary Figure S9D).
If L4440 was provided late during parent development or to
the progeny, no effect was observed. Moreover, this pheno-
type depended on the temperature in which the parents were
raised, as it occurred only when parents were transferred to
25◦C at the L1 stage and not at the L4 stage, most likely
because in this case progeny viability was already higher
(∼25%) (Supplementary Figure S9E). Taken together, these
results suggest that mir-35-41 deficiency leads to defects in
embryogenesis at 25◦C and providing an exogenous source
of dsRNA or keeping parents at permissive temperatures
(particularly the parental line) partially reverse this phe-
notype. Consistent with a direct effect of dsRNA over the
germline, a null mutation in rrf-1––a gene involved in so-
matic RNAi, but not in germline RNAi (46,47)––did not
inhibit L4440 action and rather tended to make mir-35-
41(gk262) mutants more sensitive to L4440 (Figure 5D).
DISCUSSION
This study introduces new variables to be considered in
RNAi experiments in C. elegans and potentially in other
model organisms. By treating worms with bacteria harbor-
ing widely used RNAi constructs, we report at least three
distinct ways that worms can be affected by the presence of
foreign dsRNA. First, we confirmed previous observations
that LacZ-containing transgenes, like irIs25, are silenced
by the L4440 RNAi vector (18). Importantly, this previous
study suggested that the effect of L4440 was limited to a spe-
cific class of LacZ-containing transgenes. Here, we provide
data showing that L4440 is capable of producing dsRNA
to silence a wide range of multicopy transgenes (including
GFP-expressing transgenes) and demonstrate new mecha-
nisms of L4440-mediated silencing. For example, we found
that the muIs109 transgene is silenced mostly at the mature
mRNA level by dsRNA produced by the MCS of the L4440
vector. Consistently, silencing occurs to a much lesser mag-
nitude or does not occur at all when the MCS is partially
or totally removed from the L4440 plasmid. We also show
that administration of exogenous dsRNA partially reverses
embryonic viability in an mir-35-41(gk262) deficient back-
ground via a mechanism dependent on the canonical RNAi
pathway. These findings not only imply that current RNAi
technology in C. elegans may lead to unexpected outcomes
that need to be controlled and accounted for in most ap-
plications, but also bring insights into a new level of cross-
regulation between different small RNA pathways to con-
trol embryonic development.
Given the broad implication of these findings, we de-
cided to explore how the MCS of L4440 silences transgenes.
We found that carryover sequences from pBluescript-based
vectors used to generate GFP-tagged transgenes share se-
quence similarity with the MCS of the L4440 vector. This
is somewhat expected since the L4440 vector is also a modi-
fied version of the pBluescript plasmid. In contrast, GFP se-
quences from pUC19-based transgenes, which lack relevant
sequence complementarity with the L4440 vector, are not
silenced by L4440. Furthermore, transgenes inserted with
techniques such as MosSCI or CRISPR are not affected
by L4440. These results suggest that GFP derived from
pBluescript-based plasmids should be avoided for transgene
construction in strains where L4440-mediated RNAi will
be used. In this case, the dsRNA produced by the L4440
MCS can silence transgenes when corresponding pBlue-
script vector sequences remain in the construct. Based on
double RNAi screening and further validation using mu-
tants, we found that the L4440 MCS requires both canon-
ical (i.e. dcr-1, rde-1, rde-4 and mut-16) and non-canonical
(i.e. drh-1 and rsd-6) members of the RNAi pathway to si-
lence transgenes. DRH-1 and RSD-6 have been shown to
play a role in the antiviral RNAi pathway in C. elegans
(41,42), although RSD-6 was first described as a protein
necessary for systemic RNAi, and therefore can also partic-
ipate in the canonical RNAi pathway (48). We found that
while daf-16 RNAi silences the muIs109 transgene even in
the absence of DRH-1 or RSD-6, L4440 cannot do so under
some circumstances. Interestingly, this epistatic interaction
is only observed when L4440 is offered concomitantly with
either drh-1 or rsd-6 RNAi and not when L4440 is given
to drh-1 or rsd-6 mutants. Such discrepancies are unlikely a
consequence of unspecific effects of the drh-1 or rsd-6 RNAi
clones, which differ largely in sequence. Dilution of L4440 in
the double RNAi experiments is also unlikely, since several
other RNAi clones did not influence the effects of L4440 in
our double RNAi screen and even conditions with low or
no IPTG (i.e. very low dsRNA expression) elicited L4440-
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Table 2. Double RNAi screen to assess genes necessary for L4440-mediated muIs109 (daf-16p::GFP::DAF-16 cDNA + odr-1p::RFP) transgene silencing.
Gene Single RNAi Double RNAi Function
cdi-1 Not silenced Silenced Nucleotidyltransferase
csr-1 Not silenced Silenced 22G-RNA Argonaute
dcr-1 Not silenced Not silenced microRNA and siRNA processing
drh-1 Not silenced Not silenced Helicase of the RNAi antiviral pathway
ekl-1 Not silenced Silenced RNAi pathway
ergo-1 Not silenced Silenced 26G-RNA Argonaute
eri-9 Not silenced Silenced DICER-interacting protein
hda-4 Not silenced Silenced Histone deacetylase 4
hrde-1 Not silenced Silenced Nuclear Argonaute
ire-1 Not silenced Silenced Kinase/Endoribonuclease; UPR activator
mut-14 Not silenced Silenced Putative DEAD box RNA helicase
mut-16 Not silenced Not silenced Activity required for RNAi
mut-7 Not silenced Silenced Homolog of RNAseD
nrde-2 Not silenced Not silenced Nuclear RNAi factor
nrde-3 Not silenced Not silenced Nuclear RNAi factor
pash-1 Not silenced Silenced microRNA biogenesis
prg-1 Not silenced Silenced piRNA-binding Argonaute
rde-1 Not silenced Not silenced Activity required for RNAi
rde-4 Not silenced Not silenced Activity required for RNAi
rsd-6 Not silenced Not silenced RNAi spreading protein, component of antiviral RNAi pathway
unc-130 Not silenced Silenced Regulation of clustered 21U-RNA loci
In the ‘Single RNAi’ column, we describe the effect of the RNAi clone (‘Gene’) alone on transgene expression. In the ‘Double RNAi’ column, we describe
the effect of the RNAi clone (‘Gene’) mixed 1:1 with HT115 harboring L4440 on transgene expression. Not silenced, when the majority of the worms had
at least 20% of the intestinal cells with nuclear GFP localization. Silenced, when the majority of the worms had less than 20% of the intestinal cells with
nuclear GFP localization. Bold rows represent RNAi clones that blocked the L4440 effect. This experiment was performed twice with at least eight worms
per condition.














cdi-1 13.01 ± 1.67 27.13 ± 1.63 29.73 ± 2.01 30.34 ± 1.05 P < 0.0001 P = 0.5137
csr-1 11.68 ± 1.67 28.56 ± 1.63 28.45 ± 2.01 29.79 ± 1.05 P < 0.0001 P = 0.9498
dcr-1 11.43 ± 2.99 26.98 ± 1.59 26.06 ± 2.53 15.93 ± 2.65 P = 0.0028 P = 0.0298
drh-1 18.32 ± 3.49 34.74 ± 2.50 39.05 ± 2.56 41.70 ± 5.77 P = 0.0071 P = 0.5835
ekl-1 10.92 ± 1.34 23.67 ± 2.22 28.98 ± 2.29 27.15 ± 1.75 P < 0.0001 P = 0.5955
ergo-1 9.74 ± 1.86 37.76 ± 12.30 49.88 ± 4.26 40.34 ± 1.12 P < 0.0001 P = 0.9021
eri-9 12.30 ± 1.18 27.34 ± 2.95 27.70 ± 2.17 25.87 ± 2.48 P = 0.0007 P = 0.9680
hda-4 16.48 ± 2.89 34.40 ± 2.71 34.83 ± 2.29 36.18 ± 5.57 P = 0.0090 P = 0.9850
hrde-1 11.32 ± 1.06 23.61 ± 2.37 23.18 ± 1.95 22.42 ± 1.59 P = 0.0009 P = 0.9659
ire-1 13.82 ± 1.45 38.58 ± 2.09 43.19 ± 5.35 44.62 ± 3.93 P < 0.0001 P = 0.6338
mut-14 8.19 ± 1.88 36.36 ± 2.42 41.68 ± 3.35 30.89 ± 3.78 P < 0.0001 P = 0.5673
mut-16 15.79 ± 1.37 30.84 ± 2.98 40.67 ± 5.04 42.55 ± 4.09 P = 0.0005 P = 0.1381
mut-7 12.97 ± 1.62 22.58 ± 0.93 26.27 ± 1.36 15.00 ± 1.50 P < 0.0001 P = 0.0048
nrde-2 12.66 ± 1.27 39.93 ± 3.50 52.07 ± 3.96 54.50 ± 4.11 P = 0.0002 P = 0.0647
nrde-3 13.83 ± 3.45 31.19 ± 3.74 37.85 ± 5.04 46.17 ± 4.10 P = 0.0068 P = 0.0993
pash-1 14.60 ± 3.83 30.76 ± 3.12 11.52 ± 1.42 10.11 ± 2.72 P = 0.8765 P = 0.0004
prg-1 13.10 ± 2.79 31.07 ± 7.50 21.22 ± 1.66 19.37 ± 2.62 P = 0.5511 P = 0.2492
rde-1 12.54 ± 1.36 28.66 ± 3.79 29.47 ± 1.27 18.02 ± 3.18 P = 0.0004 P = 0.0370
rde-4 13.81 ± 1.91 26.53 ± 1.50 17.75 ± 1.42 17.12 ± 1.32 P = 0.3091 P = 0.0020
rsd-6 11.91 ± 2.04 26.06 ± 3.96 15.33 ± 1.26 19.58 ± 1.67 P = 0.7620 P = 0.2768
unc-130 13.37 ± 0.96 26.68 ± 1.42 23.69 ± 1.36 24.46 ± 1.83 P = 0.0003 P = 0.6967
In the ‘Single RNAi’ column, we describe the effect of the RNAi clone (‘Gene’) alone. In the ‘Double RNAi’ column, we describe the effect of the RNAi
clone (‘Gene’) mixed 1:1 with HT115 harboring L4440. Bold rows represent RNAi clones in which the viability of the ‘double RNAi’ group was statistically
different from the ‘L4440’ group. One-way ANOVA and Tukey’s multiple comparison post-hoc tests were performed. Experiments were repeated four to
five times with at least nine worms per group each time.
Nonetheless, differently from when rsd-6 is silenced in lar-
vae, silencing in utero does not significantly affect the abil-
ity of L4440 to suppress the muIs109 transgene (Supple-
mentary Figure S8C). This suggests that the difference be-
tween the double RNAi experiments and the experiments
where we applied L4440 to mutant worms is timing. While
in the mutants drh-1 and rsd-6 are constitutively absent, in
our double RNAi screen genes were silenced concomitantly
with the administration of L4440 starting at the L1 stage.
The former could induce a compensatory, redundant path-
way to deal with foreign dsRNA during early embryonic de-
velopment even in the absence of drh-1 and rsd-6. Indeed, it
is expected that during embryogenesis cells use redundant
pathways to preserve genomic integrity and reduce tran-
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Figure 5. Unspecific RNAi reverses the phenotype of decreased progeny viability of mir-35-41(gk262)/VC514 mutants. (A) Percentage of viable progeny
of N2 and mir-35-41(gk262)/VC514 hermaphrodite mutants when grown at 25◦C in HT115 and crossed with males of their respective background grown
at permissive temperature (15◦C). For the experimental group (third bar), MAM130/mir-35(gk262) II, wwIs8 [mir-35-41p::GFP + unc-119(+)]) males
were grown for 60 h at 15◦C and then crossed with a single mir-35-41(gk262) hermaphrodite that was grown for 50 h at 25◦C. The worms were left mating
for 24 h at 25◦C. After that, GFP positive eggs were counted. Later, L3 worms were counted and viable progeny was calculated. As controls, N2 males were
crossed with N2 hermaphrodite (first bar) or mir-35-41(gk262)/VC514 strain was grown at 25◦C (second bar) or 15◦C (fourth bar) and viable progeny
was evaluated. a, b, c and d represent P < 0.05 in comparison to all the other groups according to one-way ANOVA with Tukey’s multiple comparison
post-hoc test. The experiments were repeated four times with at least nine worms scored per group in each experiment. (B) The mir-35-41(gk262)/VC514
mutants show progeny viability of 5% at 25◦C. Percent of viable progeny represents the average number of eggs laid that reached the L3 stage. L4440* is
a L4440 plasmid from another laboratory (Dr Andrew Chisholm). **P < 0.01 L4440 plus IPTG versus minus IPTG. The experiment was repeated two
times with at least 276 worms per group. (C) Percent of viable progeny when worms were injected with buffer or dsRNA targeting GFP (dsGFP RNA).
About 43 worms per parent were measured. mir-35(gk262);ccIs4251[myo-3p::GFP(NLS)::LacZ + myo-3p::GFP] strain were used in this experiment, so
we could monitor whether injection with gfp RNAi worked. *P < 0.05 dsGFP versus buffer. (D) Worms were grown in NGM plates with HT115 harboring
L4440 in the presence or not of IPTG for dsRNA induction. Percent viability represents percent progeny that grew up to L3. Results are from at least two
independent experiments. At least 85 worms per parent were measured. P values for L4440 (-) IPTG versus L4440 (+) IPTG using unpaired t-test are:
mir-35(gk262): 0.0678; mir-35(gk262); rde-1(ne300): 0.0282; mir-35(gk262); rde-4(ne301): 0.1815; mir-35(gk262); rrf-1(pk1417): 0.0007.
ple where redundant genes can compensate for mutations
but not RNAi-mediated silencing (49).
Like the muIs109 transgene, the mamIs1 and mamIs2
transgenes are also silenced by L4440. The dcr-1 overex-
pressing constructs were made using the pPD95.75 plas-
mid (27)––a pBluescript-based vector. However, unlike the
muIs109 transgene, the dcr-1 transgenes are silenced by mul-
tiple RNAi clones lacking part or the entire MCS. These re-
sults suggest that this silencing mechanism is independent
of the MCS and may be similar to the one observed by Gr-
ishok et al., even though we could not find sequences com-
plementary to the LacZ gene in the backbone of pPD95.75.
We could nonetheless identify significant sequence overlap
between the backbones of pPD95.75 and L4440, indicat-
ing that transgene silencing may be mediated by such over-
lap (Supplementary Material). Moreover, RNA produced
by the L4440 backbone could exacerbate an already exist-
ing RNAi-dependent silencing process normally occurring
in the soma for repetitive transgenes (18,50). Accordingly, it
was recently demonstrated that the L4440 vector does not
present T7 terminator sequences and therefore T7-mediated
transcription leads to backbone sequence expression (51).
These results hint that L4440 could interfere with a wide va-
riety of transgenes in C. elegans, particularly the ones where
sequences of pBluescript vectors remain in the construct.
We also found that RNAi may result in undesirable ef-
fects over the animal’s physiology. We show that reduced
embryonic viability in mir-35-41(gk262) mutants is par-
tially reversed in the presence of exogenous dsRNA includ-
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Figure 6. Working models on how exogenous dsRNA may interfere with transgenic and non-transgenic worms. (A) Transgenic worms grown in the
presence of dsRNA have their transgene silenced by sequences produced by the RNAi vector. This mechanism involves the canonical RNAi pathway
(blue) and some other non-canonical players (red). (B) The mir-35-41 cluster is highly expressed in C. elegans germline and when absent causes a decrease
in progeny viability. This can be partially reversed by exogenously provided dsRNA molecules. This could be potentially explained by changes in endogenous
small RNA production/function and/or miR-35-41 targets, which in turn would affect progeny viability.
the effect of L4440 was dependent on an upstream com-
ponent of the canonical siRNA processing machinery (i.e.
RDE-4) as assessed first by the double RNAi screen and
confirmed by crossing mir-35-41(gk262) with rde-4(ne301)
mutants. An intriguing possibility to explain this phenotype
is a role for the mir-35-41 cluster as a sponge for RNA-
binding proteins and components of the RNAi pathway. In-
deed, mir-35-41 are among the most highly expressed miR-
NAs in oocytes and during early embryonic development
(17,52,53), and their absence could alter the stoichiometric
balance between the miRNA biogenesis and RNAi path-
ways (15), possibly affecting the production of endogenous
small RNAs that impair progeny viability (Figure 6). The
presence of abundant exogenous dsRNA would in turn re-
balance the stoichiometry and restore viability.
Our model is consistent with the fact that mir-35-41 de-
ficiency leads to RNAi hypersensitivity (15) and that al-
most all RNAi clones that we tested partially recover the
viability of mir-35-41(gk262) mutant progeny, while defi-
ciency in the miRNA pathway (as demonstrated by pash-1
RNAi) sensitizes mir-35-41(gk262) mutants to reduced em-
bryonic viability, probably by further promoting the flux of
small RNA biogenesis toward other branches of the path-
way. Alternatively, exogenous dsRNA may potentially sup-
press targets of mir-35-41 such as germline RNA-binding
proteins like GLD-1 and SUP-26, which genetically interact
with mir-35-41 to control progeny development (17,43,54).
A search in Pubmed for ‘elegans AND (RNAi OR RNA
interference)’ retrieved 3353 published papers as of Febru-
ary 2019. It is safe to speculate that the majority of these
papers or upcoming publications have used or will use the
L4440 vector at some point, given that the two C. ele-
gans RNAi libraries available were constructed using this
vector. Furthermore, pBluescript-based plasmids such as
pPD103.87 and pPD95.75 are a common way to shuttle and
express transgenes in C. elegans (55). Reverse genetics us-
ing L4440 as a vector for RNAi feeding has been applied to
other organisms namely Daphnia melanica, Ephydatia muel-
leri, Euplotes eurystomus, Helicoverpa armigera, Mythimna
separate, Paramecium octaurelia, Spodoptera exigua and
Tethya wilhelma (56–62). In light of our results, these obser-
vations raise a concern regarding how one should control
RNAi experiments going forward, how transgenes should
be used to genetically modify animals and how RNAi vec-
tors should be designed to avoid unnecessary sequences. We
propose some aspects that need to be considered such as:
(i) always testing for the effect of the control vector, (ii) re-
moving the MCS of L4440 or replacing it for an unspecific
DNA fragment like the luciferase gene, (iii) using alterna-
tive RNAi vectors that share less sequence complementarity
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present T7 terminator sequences such as the one recently
proposed by Sturm et al. (51), (v) mixing bacteria harbor-
ing the RNAi clone targeting the gene of interest with bac-
teria harboring the control vector (empty or otherwise) in
all conditions to account for unspecific effects of the con-
trol vector, (vi) dosing the dsRNA levels to achieve effi-
cient silencing without overloading the RNAi machinery,
(vii) avoiding pBluescript vector sequences within trans-
genes and/or (viii) using CRISPR or MosSCI techniques
to create reporter strains for RNAi screens. In conclusion,
our work has cautionary implications for RNAi studies in
C. elegans and provides new insights into the complex inter-
play between foreign dsRNA and animal physiology.
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